‘Potential strategy to treat ovarian cancer identified’

29 April 2014

Scientists that have been examining cancerous tumour tissues believe they have identified a new strategy that could potentially treat ovarian cancer, according to the University of Manchester.

The NHS states that this particular form of the disease affects over 6,500 women every year in the UK and is the fifth most common cancer among the female population. As many are often diagnosed at later stages, prognosis is poor.

Recently developed drugs that target a tumour’s blood supply have increased survival rates, but patients can develop a resistance to such therapies.

Now, a team of researchers from the university claim that by simultaneously blocking “several avenues” cancerous cells often use to escape being destroyed, the treatment will be more effective.

Professor Gordon Jayson, lead author of the study, said: “Targeting multiple factors and blocking several avenues that tumour cells use to escape eradication at the same time may be a better strategy than current drugs, which target only one molecule.” 

Posted by Philip Briggs

 

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:

or

Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.

or

Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

Categories

Cancer

© Spire Healthcare Group plc (2016)